Characterization of severe asthma in the pediatric population

Vasquez Perez, Amalui; Bobé Pol, Anna; Rua Hernandez, Elizabeth; García Lorenzo, Marc; Gomez Serra, Alba; Bosque-García, Montserrat.
Allergol. immunopatol ; 49(2): 60-65, mar. 2021. tab
Artículo en Inglés | IBECS (España) | ID: ibc-214239

Documentos relacionados

  1. Characterization of severe asthma in the pediatric population.
  2. Super-responder and clinical remission in patients with asthma on treatment with single biologic therapy or cycling therapy using dupilumab in a real-world setting.
  3. Mild asthma: Conundrums, complexities and the need to customize care.
  4. Home administration of biological treatment in severe asthma in real-life experience: impact on asthma control and quality of life.
  5. Real-life experience after 3 months with tezepelumab before marketing approval.
  6. Burden and unmet need for specialist care in poorly controlled and severe childhood asthma in a Danish nationwide cohort.
  7. Barriers to clinical remission in severe asthma.
  8. Exploration of the efficacy of anti-immunoglobulin E monoclonal antibodies in the treatment of allergic asthma.
  9. Precision care in the treatment of pediatric asthma.
  10. Prospective study of disease persistence and lung function trajectories of childhood asthma.